Report Detail
COVID-19 Impact on Global Cardiac Biomarker, Market Insights and Forecast to 2026
- RnM4080628 |
- 26 June, 2020 |
- Global |
- 112 Pages |
- QYResearch |
- Pharma & Healthcare
Cardiac Biomarker market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cardiac Biomarker market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Cardiac Biomarker market is segmented into
Creatine kinase (CK) MB
Troponin (cTnI and cTnT)
BNP & NT-proBNP
Myogloblin
Others (hs-CRP, D-Dimer, etc.)
Segment by Application, the Cardiac Biomarker market is segmented into
Myocardial Infarction
Congestive Heart Failure
Acute Coronary Syndrome
Atherosclerosis
Others
Regional and Country-level Analysis
The Cardiac Biomarker market is analysed and market size information is provided by regions (countries).
The key regions covered in the Cardiac Biomarker market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Cardiac Biomarker Market Share Analysis
Cardiac Biomarker market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Cardiac Biomarker business, the date to enter into the Cardiac Biomarker market, Cardiac Biomarker product introduction, recent developments, etc.
The major vendors covered:
Abbott
Roche Diagnostics
BG Medicine
Biomerieux
Critical Diagnostics
DiaDexus
Response Biomedical
Siemens Healthcare
Singulex
Thermo Scientific
1 Study Coverage
- 1.1 Cardiac Biomarker Product Introduction
- 1.2 Market Segments
- 1.3 Key Cardiac Biomarker Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Cardiac Biomarker Market Size Growth Rate by Type
- 1.4.2 Creatine kinase (CK) MB
- 1.4.3 Troponin (cTnI and cTnT)
- 1.4.4 BNP & NT-proBNP
- 1.4.5 Myogloblin
- 1.4.6 Others (hs-CRP, D-Dimer, etc.)
- 1.5 Market by Application
- 1.5.1 Global Cardiac Biomarker Market Size Growth Rate by Application
- 1.5.2 Myocardial Infarction
- 1.5.3 Congestive Heart Failure
- 1.5.4 Acute Coronary Syndrome
- 1.5.5 Atherosclerosis
- 1.5.6 Others
- 1.6 Coronavirus Disease 2019 (Covid-19): Cardiac Biomarker Industry Impact
- 1.6.1 How the Covid-19 is Affecting the Cardiac Biomarker Industry
- 1.6.1.1 Cardiac Biomarker Business Impact Assessment - Covid-19
- 1.6.1.2 Supply Chain Challenges
- 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
- 1.6.2 Market Trends and Cardiac Biomarker Potential Opportunities in the COVID-19 Landscape
- 1.6.3 Measures / Proposal against Covid-19
- 1.6.3.1 Government Measures to Combat Covid-19 Impact
- 1.6.3.2 Proposal for Cardiac Biomarker Players to Combat Covid-19 Impact
- 1.6.1 How the Covid-19 is Affecting the Cardiac Biomarker Industry
- 1.7 Study Objectives
- 1.8 Years Considered
2 Executive Summary
- 2.1 Global Cardiac Biomarker Market Size Estimates and Forecasts
- 2.1.1 Global Cardiac Biomarker Revenue 2015-2026
- 2.1.2 Global Cardiac Biomarker Sales 2015-2026
- 2.2 Cardiac Biomarker Market Size by Region: 2020 Versus 2026
- 2.2.1 Global Cardiac Biomarker Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Cardiac Biomarker Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Cardiac Biomarker Competitor Landscape by Players
- 3.1 Cardiac Biomarker Sales by Manufacturers
- 3.1.1 Cardiac Biomarker Sales by Manufacturers (2015-2020)
- 3.1.2 Cardiac Biomarker Sales Market Share by Manufacturers (2015-2020)
- 3.2 Cardiac Biomarker Revenue by Manufacturers
- 3.2.1 Cardiac Biomarker Revenue by Manufacturers (2015-2020)
- 3.2.2 Cardiac Biomarker Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Cardiac Biomarker Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Cardiac Biomarker Revenue in 2019
- 3.2.5 Global Cardiac Biomarker Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Cardiac Biomarker Price by Manufacturers
- 3.4 Cardiac Biomarker Manufacturing Base Distribution, Product Types
- 3.4.1 Cardiac Biomarker Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Cardiac Biomarker Product Type
- 3.4.3 Date of International Manufacturers Enter into Cardiac Biomarker Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
- 4.1 Global Cardiac Biomarker Market Size by Type (2015-2020)
- 4.1.1 Global Cardiac Biomarker Sales by Type (2015-2020)
- 4.1.2 Global Cardiac Biomarker Revenue by Type (2015-2020)
- 4.1.3 Cardiac Biomarker Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Cardiac Biomarker Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Cardiac Biomarker Sales Forecast by Type (2021-2026)
- 4.2.2 Global Cardiac Biomarker Revenue Forecast by Type (2021-2026)
- 4.2.3 Cardiac Biomarker Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Cardiac Biomarker Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
- 5.1 Global Cardiac Biomarker Market Size by Application (2015-2020)
- 5.1.1 Global Cardiac Biomarker Sales by Application (2015-2020)
- 5.1.2 Global Cardiac Biomarker Revenue by Application (2015-2020)
- 5.1.3 Cardiac Biomarker Price by Application (2015-2020)
- 5.2 Cardiac Biomarker Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Cardiac Biomarker Sales Forecast by Application (2021-2026)
- 5.2.2 Global Cardiac Biomarker Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Cardiac Biomarker Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Cardiac Biomarker by Country
- 6.1.1 North America Cardiac Biomarker Sales by Country
- 6.1.2 North America Cardiac Biomarker Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Cardiac Biomarker Market Facts & Figures by Type
- 6.3 North America Cardiac Biomarker Market Facts & Figures by Application
7 Europe
- 7.1 Europe Cardiac Biomarker by Country
- 7.1.1 Europe Cardiac Biomarker Sales by Country
- 7.1.2 Europe Cardiac Biomarker Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Cardiac Biomarker Market Facts & Figures by Type
- 7.3 Europe Cardiac Biomarker Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Cardiac Biomarker by Region
- 8.1.1 Asia Pacific Cardiac Biomarker Sales by Region
- 8.1.2 Asia Pacific Cardiac Biomarker Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Cardiac Biomarker Market Facts & Figures by Type
- 8.3 Asia Pacific Cardiac Biomarker Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Cardiac Biomarker by Country
- 9.1.1 Latin America Cardiac Biomarker Sales by Country
- 9.1.2 Latin America Cardiac Biomarker Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Cardiac Biomarker Market Facts & Figures by Type
- 9.3 Central & South America Cardiac Biomarker Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Cardiac Biomarker by Country
- 10.1.1 Middle East and Africa Cardiac Biomarker Sales by Country
- 10.1.2 Middle East and Africa Cardiac Biomarker Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Cardiac Biomarker Market Facts & Figures by Type
- 10.3 Middle East and Africa Cardiac Biomarker Market Facts & Figures by Application
11 Company Profiles
- 11.1 Abbott
- 11.1.1 Abbott Corporation Information
- 11.1.2 Abbott Description, Business Overview and Total Revenue
- 11.1.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Abbott Cardiac Biomarker Products Offered
- 11.1.5 Abbott Recent Development
- 11.2 Roche Diagnostics
- 11.2.1 Roche Diagnostics Corporation Information
- 11.2.2 Roche Diagnostics Description, Business Overview and Total Revenue
- 11.2.3 Roche Diagnostics Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Roche Diagnostics Cardiac Biomarker Products Offered
- 11.2.5 Roche Diagnostics Recent Development
- 11.3 BG Medicine
- 11.3.1 BG Medicine Corporation Information
- 11.3.2 BG Medicine Description, Business Overview and Total Revenue
- 11.3.3 BG Medicine Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 BG Medicine Cardiac Biomarker Products Offered
- 11.3.5 BG Medicine Recent Development
- 11.4 Biomerieux
- 11.4.1 Biomerieux Corporation Information
- 11.4.2 Biomerieux Description, Business Overview and Total Revenue
- 11.4.3 Biomerieux Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Biomerieux Cardiac Biomarker Products Offered
- 11.4.5 Biomerieux Recent Development
- 11.5 Critical Diagnostics
- 11.5.1 Critical Diagnostics Corporation Information
- 11.5.2 Critical Diagnostics Description, Business Overview and Total Revenue
- 11.5.3 Critical Diagnostics Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Critical Diagnostics Cardiac Biomarker Products Offered
- 11.5.5 Critical Diagnostics Recent Development
- 11.6 DiaDexus
- 11.6.1 DiaDexus Corporation Information
- 11.6.2 DiaDexus Description, Business Overview and Total Revenue
- 11.6.3 DiaDexus Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 DiaDexus Cardiac Biomarker Products Offered
- 11.6.5 DiaDexus Recent Development
- 11.7 Response Biomedical
- 11.7.1 Response Biomedical Corporation Information
- 11.7.2 Response Biomedical Description, Business Overview and Total Revenue
- 11.7.3 Response Biomedical Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Response Biomedical Cardiac Biomarker Products Offered
- 11.7.5 Response Biomedical Recent Development
- 11.8 Siemens Healthcare
- 11.8.1 Siemens Healthcare Corporation Information
- 11.8.2 Siemens Healthcare Description, Business Overview and Total Revenue
- 11.8.3 Siemens Healthcare Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 Siemens Healthcare Cardiac Biomarker Products Offered
- 11.8.5 Siemens Healthcare Recent Development
- 11.9 Singulex
- 11.9.1 Singulex Corporation Information
- 11.9.2 Singulex Description, Business Overview and Total Revenue
- 11.9.3 Singulex Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 Singulex Cardiac Biomarker Products Offered
- 11.9.5 Singulex Recent Development
- 11.10 Thermo Scientific
- 11.10.1 Thermo Scientific Corporation Information
- 11.10.2 Thermo Scientific Description, Business Overview and Total Revenue
- 11.10.3 Thermo Scientific Sales, Revenue and Gross Margin (2015-2020)
- 11.10.4 Thermo Scientific Cardiac Biomarker Products Offered
- 11.10.5 Thermo Scientific Recent Development
- 11.1 Abbott
- 11.1.1 Abbott Corporation Information
- 11.1.2 Abbott Description, Business Overview and Total Revenue
- 11.1.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Abbott Cardiac Biomarker Products Offered
- 11.1.5 Abbott Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Cardiac Biomarker Market Estimates and Projections by Region
- 12.1.1 Global Cardiac Biomarker Sales Forecast by Regions 2021-2026
- 12.1.2 Global Cardiac Biomarker Revenue Forecast by Regions 2021-2026
- 12.2 North America Cardiac Biomarker Market Size Forecast (2021-2026)
- 12.2.1 North America: Cardiac Biomarker Sales Forecast (2021-2026)
- 12.2.2 North America: Cardiac Biomarker Revenue Forecast (2021-2026)
- 12.2.3 North America: Cardiac Biomarker Market Size Forecast by Country (2021-2026)
- 12.3 Europe Cardiac Biomarker Market Size Forecast (2021-2026)
- 12.3.1 Europe: Cardiac Biomarker Sales Forecast (2021-2026)
- 12.3.2 Europe: Cardiac Biomarker Revenue Forecast (2021-2026)
- 12.3.3 Europe: Cardiac Biomarker Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Cardiac Biomarker Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Cardiac Biomarker Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Cardiac Biomarker Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Cardiac Biomarker Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Cardiac Biomarker Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Cardiac Biomarker Sales Forecast (2021-2026)
- 12.5.2 Latin America: Cardiac Biomarker Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Cardiac Biomarker Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Cardiac Biomarker Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Cardiac Biomarker Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Cardiac Biomarker Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Cardiac Biomarker Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter’s Five Forces Analysis
- 13.5 Primary Interviews with Key Cardiac Biomarker Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Cardiac Biomarker Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
Summary:
Get latest Market Research Reports on COVID-19 Impact on Global Cardiac Biomarker. Industry analysis & Market Report on COVID-19 Impact on Global Cardiac Biomarker is a syndicated market report, published as COVID-19 Impact on Global Cardiac Biomarker, Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Cardiac Biomarker market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
